پاورپوینت اپیدمیولوژی سیاه زخم (pptx) 85 اسلاید
دسته بندی : پاورپوینت
نوع فایل : PowerPoint (.pptx) ( قابل ویرایش و آماده پرینت )
تعداد اسلاید: 85 اسلاید
قسمتی از متن PowerPoint (.pptx) :
1
اپیدمیولوژی سیاه زخم
الف ـ مقدمه و معرفي بيماري
1- تعريف و اهميت بهداشتي
2 – عامل يا عوامل اتيولوژيك
ب ـ اپيدميولوژي توصيفي و وقوع
(OCCURRENCE)
ج ـ پيشگيري و كنترل
Human zoonotic disease
Primarily disease of herbivorous animals
Sheep, goats, cattle
Many large documented epizootics
Occasional human disease
Epidemics have occurred but uncommon
Rare in developed world
1- تعريف و اهميت بهداشتي
Bioweapon Potential
Many countries have weaponized anthrax
Former bioweapon programs
U.S.S.R., U.S., U.K., and Japan
Recent bioweapon programs
Iraq
Attempted uses as bioterrorism agent
WW I:
Germans
inoculated Allied livestock
WW II:
Japanese
use on prisoners
Features of anthrax suitable as BT agent
Spores easily dispersed as aerosol
Moderately infectious
High mortality for inhalational (86-100%)
Fairly easy to obtain, produce and store
Bioweapon Potential
Aerosol method of delivery
Most likely method expected in BT attack
Would cause primarily inhalational disease
Spores reside on particles of 1-5
μm size
Optimal size for deposition into alveoli
Form of disease with highest mortality
Would infect the largest number of people
Bioweapon Potential
Sverdlovsk, Russia 1979
Accidental release from anthrax drying plant
79 human cases
All downwind of plant
68 deaths
Some infected with multiples strains
Bioweapon Potential
Estimated effects of inhalational anthrax
100 kg spores released
over city size of Washington DC
130,000 – 3 million deaths depending on weather conditions
Economic impact
$26.2 billion/100,000 exposed people
Bioweapon Potential
ب ـ اپيدميولوژي توصيفي و وقوع آنتراكس
1 – دوره نهفتگي
(Incubation period)
2 – سير طبيعي
(Natural course)
3 – انتشار جغرافيائي
(Geographical distribution)
4 – روند زماني
(Timeline trend)
5 – تاثير سن، جنس، شغل و موقعيت اجتماعي
6 – تاثير عوامل مساعد كننده
(Predisposing factors)
7 – حساسيت و مقاومت
(Susceptibility & Resistance)
8 – ميزان حمله هاي ثانويه
(Secondary attack rate)
9 – نحوه انتقال و دوره قابليت سرايت
(Mode of transmission & period of communicability)
1 ـ دوره نهفتگي
Incubation Period
Time from exposure to symptoms
Cutaneous
, 3-10 days
Very variable for
inhalational
2-43 days reported
Theoretically may be up to 100 days
Delayed germination of spores